chr17-10542874-C-G
Variant summary
Our verdict is Uncertain significance. Variant got 4 ACMG points: 4P and 0B. PVS1_ModeratePM2
The NM_017534.6(MYH2):c.904+1G>C variant causes a splice donor change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000393 in 1,424,064 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_017534.6 splice_donor
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MYH2 | NM_017534.6 | c.904+1G>C | splice_donor_variant | ENST00000245503.10 | NP_060004.3 | |||
MYHAS | NR_125367.1 | n.168-24663C>G | intron_variant, non_coding_transcript_variant | |||||
MYH2 | NM_001100112.2 | c.904+1G>C | splice_donor_variant | NP_001093582.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MYH2 | ENST00000245503.10 | c.904+1G>C | splice_donor_variant | 1 | NM_017534.6 | ENSP00000245503 | P1 | |||
MYH2 | ENST00000532183.6 | c.904+1G>C | splice_donor_variant | 1 | ENSP00000433944 | |||||
MYH2 | ENST00000622564.4 | c.904+1G>C | splice_donor_variant | 1 | ENSP00000482463 | |||||
MYH2 | ENST00000397183.6 | c.904+1G>C | splice_donor_variant | 5 | ENSP00000380367 | P1 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD3 exomes AF: 0.00000401 AC: 1AN: 249492Hom.: 0 AF XY: 0.00000741 AC XY: 1AN XY: 134936
GnomAD4 exome AF: 0.0000393 AC: 56AN: 1424064Hom.: 0 Cov.: 30 AF XY: 0.0000380 AC XY: 27AN XY: 710980
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
Myopathy, proximal, and ophthalmoplegia Uncertain:1
Uncertain significance, criteria provided, single submitter | curation | Broad Center for Mendelian Genomics, Broad Institute of MIT and Harvard | May 02, 2023 | The heterozygous c.904+1G>C variant in MYH2 was identified by our study, in the compound heterozygous state with a likely pathogenic variant (dbSNP ID: rs1234832404), in one individual with myopathy, limb-girdle muscle weakness, and ophthalmoplegia. This individual also carried a likely pathogenic variant (dbSNP ID: rs1234832404), however the phase of these variants are unknown at this time. The c.904+1G>C variant in MYH2 has not been previously reported in individuals with autosomal recessive proximal myopathy and ophthalmoplegia, but has been identified in 0.0009% (1/112616) of European (non-Finnish) chromosomes by the Genome Aggregation Database (gnomAD, http://gnomad.broadinstitute.org; dbSNP ID: rs879255253). Although this variant has been seen in the general population in a heterozygous state, its frequency is low enough to be consistent with a recessive carrier frequency. A different nucleotide change that also results in a splice donor variant at the same site, c.904+1G>A (ClinVar Variation ID: 183661) has been previously reported pathogenic, and the variant being assessed here, c.904+1G>C, is predicted by SpliceAI to have a similar effect on splicing. This variant is located in the 5' splice region. Computational tools predict a splicing impact, though this information is not predictive enough to determine pathogenicity. There is an in-frame cryptic splice site 99 bases from the intron-exon boundary, providing evidence that this variant may delete 33 amino acids instead of causing loss of function. However, this information is not predictive enough to determine pathogenicity. Loss of function of the MYH2 gene is an established disease mechanism in autosomal recessive proximal myopathy and ophthalmoplegia. In summary, while there is some suspicion for a pathogenic role, the clinical significance of this variant is uncertain. ACMG/AMP Criteria applied: PVS1_Moderate, PS1_Supporting, PM2_Supporting, PM3_Supporting (Richards 2015). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at